Sorted By:

Relevance


PhRMA Comment Letter on CMS Proposed Rule

PhRMA  |  Speeches & Communication

PhRMA comment on [CMS-4182-P] Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.
https://www.phrma.org

Competition in Part D Promotes Access and Helps Control Costs

Chartpack  |  From Our Network

Part D has several mechanisms that promote access and control costs.
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/competition-in-part-d-promotes-access-and-helps-control-costs

A state-by-state look at coverage and access hurdles in 2016 exchange plans

PhRMA  |  Blog Post

Be sure to look up your state here, and learn more at AccessBetterCoverage.org.
http://catalyst.phrma.org/a-state-by-state-look-at-coverage-and-access-hurdles-in-2016-exchange-plans

PhRMA Statement on Tremendous Success of BPCA and PREA

PhRMA  |  Press Release

Industry-wide research and investment reached a record $67.4 billion in 2010.
https://www.phrma.org/press-release/phrma-statement-on-tremendous-success-of-bpca-and-prea

Better Use of Medicines Yields Significant Health Gains and Savings on Other Services

Chartpack  |  From Our Network

Due to a growing body of evidence, in 2012 the Congressional Budget Office (CBO) began recognizing reductions in other medical expenditures associated with increased use of prescription medicines in Medicare....
http://chartpack.phrma.org/biophrma-chartpack/outcomes-and-savings/better-use-of-medicines-yields-significant-health-gains-and-savings-on-other-services

Together - Type 2 Diabetes

PhRMA  |  Video

That’s why patients like Angel and researchers like Laura will be tenacious in their fight to end this disease once and for all.
https://www.phrma.org

What they are saying: Rising deductibles and out-of-pocket costs in health insurance plans

PhRMA  |  Blog Post

 And visit AccessBetterCoverage.org for more.
http://catalyst.phrma.org/what-they-are-saying-rising-deductibles-and-out-of-pocket-costs-in-health-insurance-plans

Paul A. Aines Named PhRMA Executive Vice President and Chief Financial Officer; Del Persinger to Retire

PhRMA  |  Press Release

“Paul’s broad financial expertise and deep understanding of PhRMA’s critical stakeholders will help us grow as an organization and meet this great challenge.”
https://www.phrma.org/press-release/paul-a-aines-named-phrma-executive-vice-president-and-chief-financial-officer-del-persinger-to-retire

A Delicate Balance - Pharmaceutical Innovation and Access

PhRMA  |  Codes & Guidelines

Chief Medical Officer and Executive Vice President, Science and Regulatory Affairs, PhRMA published in The New England Journal of Medicine.
https://www.phrma.org

PhRMA and The ALS Association Report More Than 560 Medicines in Development for Rare Diseases

PhRMA  |  Press Release

“As we learn more and more about this debilitating disease, the prospect of a cure is becoming a reality – giving patients and their families new hope.”
https://www.phrma.org/press-release/phrma-and-the-als-association-report-more-than-560-medicines-in-development-for-rare-diseases

Policy Solutions to Foster Innovation and Access to Personalized Medicines: Delivery

Chartpack  |  From Our Network

Policies must ensure that value assessments are patient-centered and align with the way value emerges and changes over time in order to align with the rapid pace of scientific advances in personalized medicine.
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/advancing-policies-to-foster-innovation-sustaining-advances-in-personalized-medicine/policy-solutions-to-foster-innovation-and-access-to-personalized-medicines-delivery

Burden on Patients: Mental Health Disorders Can Affect Anyone and Health Insurance Exchanges Must Provide Needed Medicines

PhRMA  |  Blog Post

These treatments, however, are covered at just 58 percent and 17 percent, respectively on exchange plans.
http://catalyst.phrma.org/burden-on-patients-mental-health-disorders-can-affect-anyone-and-health-insurance-exchanges-must-pro

Embracing 21st Century Information Sharing: Defining a New Paradigm for the FDA and Communications with Health Care Professionals

PhRMA  |  Blog Post

Get updates on this subject and/or other relevant issues here.
http://catalyst.phrma.org/embracing-21st-century-information-sharing-defining-a-new-paradigm-for-the-fda-and-communications-with-health-care-professionals

PhRMA Statement on the FDA and NIH Workforce Authorities Modernization Act

PhRMA  |  Press Release

  About PhRMAThe Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-the-fda-and-nih-workforce-authorities-modernization-act

PhRMA and Lupus Foundation of America Report More Than 300 Medicines in Development for Autoimmune Diseases

PhRMA  |  Press Release

 About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org

PhRMA Statement on United States and China Public-Private Partnership on Healthcare

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-united-states-and-china-public-private-partnership-on-healthcare

PhRMA Statement on Clinical Trials, Research Collaborations and Washington Post Article

PhRMA  |  Press Release

We will continue to work toward the most effective and efficient research process that supports all participants in the ecosystem and most importantly, provides safe and effective medicines to patients in need."
https://www.phrma.org/press-release/phrma-statement-on-clinical-trials-research-collaborations-and-washington-post-article

Partnership for Prescription Assistance Celebrates 10th Anniversary of Assisting Uninsured and Underinsured Patients

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/partnership-for-prescription-assistance-celebrates-10th-anniversary-of-assisting-uninsured-and-underinsured-patients

Policy Solutions to Foster Innovation and Access to Personalized Medicines: Discovery

Chartpack  |  From Our Network

Policies must ensure an environment that provides strong intellectual property protections, advances the science, provides adequate research funding, and encourages STEM training.
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/advancing-policies-to-foster-innovation-sustaining-advances-in-personalized-medicine/policy-solutions-to-foster-innovation-and-access-to-personalized-medicines-discovery

New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS

PhRMA  |  Press Release

The projects they supported included clinics to treat patients with HIV/AIDS, education and prevention programs, initiatives to prevent mother-to-child transmission of HIV, and donations of medicines for AIDS and related diseases.
https://www.phrma.org/press-release/new-report-shows-97-medicines-and-vaccines-currently-in-development-for-hiv/aids

A Look at How to Best Promote Healthy Lifestyles and Adherence to Diabetes Medication

PhRMA  |  Blog Post

The Catalyst welcomes guest contributors including patients, stakeholders, innovators and others to share their perspectives and point of view.
http://catalyst.phrma.org/a-look-at-how-to-best-promote-healthy-lifestyles-and-adherence-to-diabetes-medication

Revised Clinical Trial Principles Reinforce PhRMA’s Commitment To Transparency and Strengthen Authorship Standards

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/revised-clinical-trial-principles-reinforce-phrma-s-commitment-to-transparency-and-strengthen-authorship-standards

New PhRMA Report: Medicines in development offer hope for osteoporosis patients and families

PhRMA  |  Blog Post

And there are 34 clinical trials ongoing across the United States studying osteoporosis treatments.
http://catalyst.phrma.org/new-phrma-report-medicines-in-development-offer-hope-for-osteoporosis-patients-and-families

3 Tiers, 4 Tiers, 5 Tiers and More – A look at tiering in health insurance exchange plans

PhRMA  |  Blog Post

  While having plans submit data is meant to increase transparency for consumers and make it easier to compare cost sharing across plans, it is actually misleading many of them about how what their out-of-pocket costs will be.
http://catalyst.phrma.org/3-tiers-4-tiers-5-tiers-and-more-a-look-at-tiering-in-health-insurance-exchange-plans

Medicare Monday: New Research on How Successfully Managing Diabetes Helps Patients and Part D Save

PhRMA  |  Blog Post

Improving medication adherence through programs like medication therapy management and other initiatives is important not only to ensure patient health, but also to help reduce costs in the health care system overall.
http://catalyst.phrma.org/medicaremonday-new-research-on-how-successfully-managing-diabetes-helps-patients-and-part-d-save

You have reviewed the first 350 results out of 2501. Each page contains 25 results. You're on page 14.

prev 13 14 15 16 17 18 next